Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers
about
Dermal penetration potential of perfluorooctanoic acid (PFOA) in human and mouse skinPerfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeabilityPrenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 yearsAssociation between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination SurveyExposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of ageEpidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)Endocrine disrupting properties of perfluorooctanoic acidRate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West VirginiaExposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. populationExploring indirect sources of human exposure to perfluoroalkyl carboxylates (PFCAs): evaluating uptake, elimination, and biotransformation of polyfluoroalkyl phosphate esters (PAPs) in the ratThe C8 health project: design, methods, and participantsDevelopmental neurotoxicity of perfluorinated chemicals modeled in vitroDo perfluoroalkyl compounds impair human semen quality?Perfluorinated chemicals and fetal growth: a study within the Danish National Birth CohortPolyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000An overview of the effects of organic compounds on women's reproductive health and birth outcomesPFOS induces behavioral alterations, including spontaneous hyperactivity that is corrected by dexamfetamine in zebrafish larvaeA critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansSocial disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a cross-sectional study within NHANES 2003-2006EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting ChemicalsModeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohortsExposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plantA prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetesPerfluorochemicals and human semen quality: the LIFE studyPFOS induces adipogenesis and glucose uptake in association with activation of Nrf2 signaling pathwayPreconception perfluoroalkyl and polyfluoroalkyl substances and incident pregnancy loss, LIFE StudySerum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USAAssociation of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.Perfluoroalkyl chemicals and chronic kidney disease in US adultsEnvironmental contaminant exposures and preterm birth: a comprehensive reviewAssociation of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2008The effects of environmental chemicals on renal functionReliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnanciesPerinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspringMetabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated ReceptorsFactors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and SwedenSertoli cells are the target of environmental toxicants in the testis - a mechanistic and therapeutic insightSerum perfluoroalkyl substances in children exposed to the World Trade Center disasterEarly Life Exposure to Endocrine Disrupting Chemicals and Childhood Obesity and NeurodevelopmentThyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).
P2860
Q23914660-0818DEAE-9166-4784-B001-16777626814AQ23924062-47DF357A-D6BE-44A9-A128-9AD321B3E414Q24609654-926FBB84-AA8A-47FA-8CBC-DDCBDA5A52FAQ24624507-260BD5FE-CFB2-4C6B-B48C-8ED11755864AQ24629288-2140C3FC-4D2C-42E3-99FE-D531B7982813Q24632957-D6F0AB78-1C17-4ED5-B1A4-122E55C0BB88Q24633469-8689642E-543B-402D-953A-9F1317ECF938Q24633826-65363702-73FE-479D-9D22-3133D3FB6902Q24633846-4F48FBC8-FD14-45CF-A171-ABF89A5E8416Q24634181-9A2FFF5E-1240-437C-9492-1424EB9D74B0Q24652791-2CAA1A50-6CE6-48E1-B077-E7A825A24AD2Q24654096-FE9D48FD-0249-4D02-AD14-7967FB3E8996Q24657367-2D8012B7-D907-42CB-95DE-17C3E8EA8D5CQ24680484-CA7E9378-69E1-4304-8F42-E31A44BBDC0FQ24680576-C4EFAD12-8142-4E67-AB83-8B7474AE852AQ26155268-374EA414-F0CD-4AE8-8139-D15646883760Q27342808-A14C0EAF-28E9-42D3-9F91-B89FF0CB90EFQ28072372-37537F47-7E4D-4E15-B9D0-3DD63082A93EQ28382832-6BF2CF98-78FC-45F6-8786-F9FB5595591CQ28383132-BBDA5D94-258E-48A6-B5BF-2F0340DC5F28Q28383653-3B4ECB57-6781-4AEC-BEFC-7CA406DDBB60Q28383912-341D68B5-CE6F-4AA8-8827-B04AA9B22E78Q28385335-80887438-B0D0-4E3A-AEBE-04B568375D02Q28385518-DFE8B94B-E102-4AFF-8471-4E25138063BCQ28385987-237CE642-2404-4752-9D48-51D6766E89A3Q28391766-01E6822C-8933-4796-A485-5A58BA0AE1FDQ28392052-83E1F44F-A9A4-45D6-84B4-8BA8DDD323C6Q28393054-AF79D3EF-D651-4452-A0FE-DFEFFC32E0BCQ28393763-79990774-C782-47DE-9FB1-0DD20E31B706Q28394154-9D1D76E3-F582-468C-9AFE-610DDAE55A57Q28396658-48799394-BCFD-4448-95B3-EF8FC8177124Q28397401-A022425F-E7DB-4B09-B8A3-097B9D72FF1AQ28397823-E3B62CF5-5146-428D-8CF0-5C5D3CCACBD7Q28539372-4E4EFF3F-4831-421E-82F4-0F9E615CF491Q28551209-CA491018-7BC8-4EA3-B510-3203C04D2077Q28553267-B99BBFE9-8655-4FFE-AD91-77E76D986986Q28601135-ED2BB154-37F5-409C-9A14-B9293A72D849Q28950531-5413872B-8B69-41A5-A161-78628DF99878Q29247894-5D15720F-FB3E-4CAE-84FC-6EF0A9236871Q30241400-E305FAAD-9EF7-43F3-86FB-CFAEAA5C93FD
P2860
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Half-life of serum elimination ...... orochemical production workers
@ast
Half-life of serum elimination ...... orochemical production workers
@en
Half-life of serum elimination ...... orochemical production workers
@nl
type
label
Half-life of serum elimination ...... orochemical production workers
@ast
Half-life of serum elimination ...... orochemical production workers
@en
Half-life of serum elimination ...... orochemical production workers
@nl
prefLabel
Half-life of serum elimination ...... orochemical production workers
@ast
Half-life of serum elimination ...... orochemical production workers
@en
Half-life of serum elimination ...... orochemical production workers
@nl
P2093
P2860
P356
P1476
Half-life of serum elimination ...... orochemical production workers
@en
P2093
Andrew M Seacat
David J Ehresman
Geary W Olsen
Jean M Burris
John L Butenhoff
John W Froehlich
Larry R Zobel
P2860
P304
P356
10.1289/EHP.10009
P577
2007-09-01T00:00:00Z